Human papillomavirus-associated anal squamous intraepithelial lesions in men who have sex with men and transgender women living with and without HIV in Karachi Pakistan: implications for screening and prevention
verfasst von:
Muslima Ejaz, Muhammad Mubarak, Tazeen Saeed Ali, Sören Andersson, Anna Mia Ekström
Anal squamous intraepithelial lesions (ASIL), strongly related to human papilloma virus (HPV) infection, is more prevalent among men who have sex with men (MSM). However, no such data are available for Pakistan yet, and neither HPV vaccination nor anal-cytology screening is implemented in Pakistan. The purpose of this first ever study was to assess the prevalence of HPV-related anal cytological abnormalities among MSM and transgender women living with and without HIV infection in Pakistan.
Methods
We conducted a cross-sectional study from March 2016 to November 2017 at sexual health centers run by the Perwaaz Trust and the National AIDS Control Program in Karachi. The study enrolled MSM and transgender women aged greater-than-and-equal-to-18-years who reported anal sex in the preceding 6 months. We collected two anal samples for liquid-based cytology and HPV type testing by PCR, and socio-demographic and behavioral data were collected through face-to face interviews. ASIL and its associations with biological and behavioral risk factors were analyzed through Cox regression for prevalence ratios (PR) and corresponding 95% confidence intervals (CIs).
Results
Out of 271 qualifying participants, 79% were MSM and 21% transgender women. The mean age was 28.8 (± 8) years. Almost 35% (93/271) of the study population had ASIL detected, ASIL was significantly more common among participants living with HIV than in HIV negative ((50/118) 42.4%; vs. (43/153) 28.1%) (p ≤ 0.001). Among ASIL, 66% (61/93) had low-grade squamous intraepithelial lesions (LSIL), and 3.6% (3/93) had high-grade squamous intraepithelial lesions (HSIL). The overall, HPV16 positivity was 35.5% (33/93) among all abnormal anal lesions and all 3 HSIL were HPV16 positive, however, HPV16 positivity could show its association with ASIL detection in univariate model only (PRcrude: 2.11(1.39–3.18)). Moreover, any HR-HPV type (PR 3.04; 95% CI 1.75–5.26), concurrent sexually transmitted infection (STI) (2.13; (1.28–3.55)) and HIV + /HPV + coinfection (1.75; (1.07–2.88)) remained independently associated with ASIL in the multivariate model.
Conclusions
Abnormal anal cytology among MSM and transgender is prevalent enough to consider optimal screening regimens. Further studies are required to see if periodic anal cytology can be made part of HIV care and treatment programs among MSM in Pakistan.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Background
Persistent infection with Human Papillomavirus (HPV)—predominantly high-risk HPV type 16 is the major cause of anal cancer [1] Over the past decade, the global incidence of anal squamous cell carcinoma (SCC), is rare and stable in the general population [2] however, it is 20 times more likely to occur in men who have sex with men (MSM) [3, 4] compared to heterosexual men [5]. The risk of anal cancer is highest in MSM living with HIV [4, 6‐8], other individuals living with HIV [9], immunosuppressed individuals [10], and women with history of HPV associated anogenital dysplasia [11]. The reported incidence of anal cancer in general population is 1.8 per 100,000 persons [12], in MSM it ranges between 19–35 cases per 100,000 and up to 88–131/100,000 in MSM living with HIV, i.e., more than 70 times more common than in the general population [9, 13‐15]. The increasing incidence of anal cancer can be associated with increases in the number of sexual partners and a higher prevalence of anal sex in the past few decades [16, 17].
Anal squamous intraepithelial lesions (ASIL) are the putative precursors of anal cancer, similar to cervical squamous intraepithelial lesions (CSILs) in cervical cancer [18‐22]. ASIL spans from low grade squamous intraepithelial lesions (LSIL) to high grade squamous intraepithelial lesions (HSIL) [23]. Approximately 90% of LSIL are caused by infection with low-risk HPV types 6 and 11 often clinically presenting as condyloma—genital warts—while infections with high-risk HPV types 16 and 18 are associated with HSIL [24]. However, persistent anal infection with both low-risk or high-risk HPVs and related ASILs have been associated with an increased risk for invasive anal cancer [24, 25]. Both people living with HIV and MSM generally have a higher prevalence and incidence of anal canal and perianal HSIL [21, 26]. The impact of antiretroviral therapy (ART) for HIV appears to be very limited in terms of reducing the risk of HSIL or squamous cell cancer of the anal canal and perianal region [27, 28].
Anzeige
Although there is a dearth of evidence-based uniform screening recommendations as well as benefits verses harm appraisals [29], however, recent research suggests that anal Papanicolaou (Pap) screening may have utility in preventing anal cancer [30‐32], and is cost-effective screening method for anal cancer prevention among MSM [30, 33] Anal cytology can be used as a standard screening tool for individuals at risk for anal cancer to detect early stage ASIL as screening tests used for cervical cytology [24, 34, 35]. High levels of abnormal cytology have consistently been reported among previously unscreened MSM both without (12–32%) and with (34–58%) HIV [36‐38] in various settings.
Anal cytology screening and preventive treatment programs for MSM have not yet been routinely adopted by Pakistan for multiple reasons, including an absence of local prevalence estimates, sufficient clinical expertise and infrastructure and updated guidelines for the management of sexually transmitted infections (STI). To contribute evidence for future policy, prevention, screening and management of the anal cancer burden in Pakistan, we studied HPV, ASIL, STIs and associated socio-demographic, behavioral and clinical factors among MSM and transgender women with and without HIV infection in Karachi, Pakistan.
Methods
Study design and study setting
A cross-sectional study was conducted from March 2016 to November 2017 among MSM and transgender women aged ≥ 18 years who reported having had anal sex in the preceding 6 months. Using snowball and peer referral sampling techniques, participants were recruited from a male sexual health clinic run by community-based organization Perwaaz Trust in Karachi, Pakistan. The Perwaaz Trust provides information and screening for STI, HIV testing and counseling and other health care services to MSM. We also recruited MSM and transgender women with known HIV infection from a public sector HIV and ART center run by the National AIDS Control Program of the Government of Pakistan, situated at the Civil Hospital in Karachi. This is the largest (1900-bed) tertiary care public hospital in Karachi and is a large public research and teaching hospital attached to the Dow University of Health Sciences, Karachi. Consecutive MSM and transgender women living with HIV who were attending their quarterly visits at the center between March 2016 to November 2017 were invited to participate. The study was approved by the Human Research Ethics Committee of The Aga Khan University (3612-CHS-ERC-15) and Dow University of Health Sciences Karachi Pakistan (IRB-557/DUHS/APPROVAL/2015/84).
Study procedure
After explaining the purpose of the study and study procedures, potential participants were asked to provide written informed consent. Thereafter, they were invited to participate in a face-to-face interview and to provide anal samples to detect the presence of HPV as well as any cytological lesions in the perianal area and the anal canal. A blood sample was obtained for confirmation of their HIV status (through Architect HIV Ag–Ab Combo kit by ABBOTT), viral load and CD4 + T-cell count (through FACS Count TM flow cytometry, Becton Dickinson Co., Franklin Lakes, NJ, USA). Participants were informed that they were free to interrupt the interview or withdraw from the study at any time without any negative consequences in terms of clinical services provided to them.
Anzeige
Data collection
A validated structured questionnaire with 45 questions was administered by the principal investigator (ME) and a trained data collector in a confidential space to collect information on participants’ socio-demographic characteristics, sexual behavior (the past 6 months), reproductive and medical history, HIV history, any anal disease and any use of ART. The interview lasted for an average of 35–40 min. To establish the validity of the questionnaire, pilot testing was done on 10% of the sample size. A local panel of experts established content validity. Internal consistency of the questions was established by Cronbach’s alpha wherein values between 0.70 and 0.90 were obtained. Data were coded by the principal investigator (ME) and entered by two independent data operators. Data were validated and corrected for any disparity. Frequencies were run on data for logical error checking and for any discrepancy, and study participants who had given their consent to be contacted were contacted through telephone or asked when visiting the study settings for correction of any errors.
Biological sample collection
In order to exclude the presence of any ano-genital warts, all participants underwent an inspection of their external genitalia and perianal area by a trained physician who also collected an anal sample using a moistened sterile Dacron swab (Copan Diagnostics Inc, Corona, CA, USA). The swab was inserted 3–5 cm into the anus without any direct visualization and then rotated against the anal canal wall for a minute before being removed slowly in a spiral fashion. Immediately after sampling, the swab was inserted into 3 mL of a methanol-based fixative, a sample transport medium (Universal Transport medium, Corona CA, USA), and transferred to a pathology laboratory for cytological assessment by two experienced cytopathologists at the Sindh Institute of Urology and Transplantation. About 0.5 ml of the cell suspension from the collected sample was drawn with an adjuster and put into a disposable Shandon EZ mega funnel for smear preparation in a cytospin. Glass slides were labelled and fixed into the megafunnel. The sample was centrifuged at 1000 rpm for 10 min. After 10 min, the slides were removed from the cytospin, fixed in alcohol and stained with both hematoxylin and eosin (HE) stain and Papanicolaou stain. The anal cytology was classified using the Bethesda criteria for cervical cytology [39]. Abnormal cytology was classified as atypical squamous or epithelial cell abnormalities, including atypical squamous cells of undetermined significance (ASCUS), LSIL, atypical squamous cells that do not exclude high-grade lesions (ASC-H) and HSIL [39].
HPV-testing was performed on anal PreservCyt® specimens using Polymerase Chain Reaction (PCR) for detection of low-risk (6/11) and high-risk (group 1) genotypes (16/18/31/33/35/39/45/52/56/58/59).
Statistical analysis and study variables
In total, 298 men and transgender women were recruited, out of which 27 (9.0%) were excluded from the cytological analyses due to insufficient biological material and thus omitted from the statistical analyses as well. Data analyses were performed using SPSS version 24.0 (Statistical Package for Social Sciences TX, USA). The prevalence of ASIL and 95% confidence intervals (CI) were calculated using the exact binomial method. The associations between biological and behavioral risk factors (independent variables) and cytologically identified ASIL (dependent variable) were analyzed using Cox regression hazard model algorithms with robust SEs to estimate prevalence ratios (PRs) and corresponding 95% CI. Biological determinants included HIV status; anal STIs, i.e., gonorrhoea (Neisseria gonorrhoeae), trichomonas and anal warts diagnosed or reported in the last 6 months; and anal HPV infection as determined by PCR. Anal symptoms including anal bleeding, itching or any pus discharge were also considered. Behavioral factors included number of sexual partners, consistent (always) condom use, smoking status (yes/no, if yes age at initiation; average number of cigarettes per day < 10, between 10 and 20, > 10; and were cigarettes filtered or unfiltered) and drinking alcohol (yes/no, if yes how many times; < 5 times, between 5 and 10, or more than 10 times/week) were also analyzed for their association with the dependent variable ASIL. A t-test was also performed to compare the mean number of types of HPV infections between those with and without ASIL.
Results
This study included a total of 118 participants living with HIV and 153 without HIV in the final cytological and statistical analyses. Those living with HIV were significantly older than HIV negative participants (30.9 versus 27.2; p ≤ 0.001), among PLWH 89.3% were on combination ART, 74.8% had recent CD4 count of more than 350 cells/μl) and nearly two-thirds (76.3%) had undetectable HIV viral load at their last assessment. There were also significant differences in the duration of sex work, number of sexual partners, receptive anal intercourse, and inconsistent condom use at anal intercourse in the last 6 months between study participants living with versus without HIV (Table 1).
Table 1
Socio-demographic and lifestyle characteristics of MSM and Transgender women living with and without HIV also stratified on HIV Status
Characteristics
Study population
(N = 271)
HIV positive
(N = 118)
HIV negative
(N = 153)
p-value
Mean (± SD)
28.8 (± 8.06)
30.9 (± 0.70)
27.0 (± 0.59)
< 0.001
Age categories in years n (% ages)
< 25
90 (33.2)
23 (19.5)
67 (43.8)
< 0.001
25–29
84 (31.0)
38 (32.2)
46 (30.1)
30–34
36 (13.3)
19 (16.1)
17 (11.1)
≥ 35
61 (22.5)
38 (32.2)
23 (15.0)
Marital status n (% ages)
0.001
Unmarried
211 (77.9)
79 (66.9)
132 (86.4)
Married
53 (19.6)
34 (28.8)
19 (12.4)
Separated/divorced
7 (2.5)
05 (4.3)
02 (1.2)
Smoking history
Current status: n (% ages)
Yes
210 (77.5)
99 (83.9)
111 (72.5)
0.02
Age at smoking initiation in years mean (± SD)
16.5 (± 4.9)
15.5 (± 4.2)
18.0 (± 95.7)
< 0.001
Average number of cigarettes/day n (% ages)
< 10
118 (56.2)
50 (50.0)
68 (64.8)
0.02
10–20
65 (31.0)
34 (34.0)
31 (29.5)
> 20
27 (12.8)
16 (16.0)
6(5.7)
Duration of smoking in years Mean (± SD)
12.4 (± 8.5)
14.83 (± 9.0)
10.15 (± 7.7)
< 0.001
< 5 years n (%)
60 (28.6)
16 (16.0)
44 (39.6)
< 0.001
5–10 years n (%)
51 (24.3)
21 (21.0)
30 (27.0)
11–15 years n (%)
64 (30.5)
39 (39.0)
26 (23.4)
> 15 years n (%)
35 (16.6)
24 (24.0)
11 (9.9)
Sexual behaviors
Sexual identity n (% ages)
Bisexual
58 (21.4)
34 (29.8)
24 (17.4)
0.008
Homosexual
156 (57.6)
55 (45.0)
101 (64.7)
Transgender
57 (21.0)
33 (25.2)
24 (17.9)
Sex worker characteristics n (%)
215 (79.3)
91 (77.1)
124 (81.0)
0.43
Age first had sexual intercourse (in years) mean (± SD)
16.42 (± 4.7)
15.13 (± 3.8)
17.44 (± 5.1)
< 0.001
Duration of sex-work in-years mean (± SD)
12.42 (8.2)
15.76 (8.3)
9.8 (7.1)
< 0.001
Anal receptive sexual partners the last 6 months n (% ages)*
< 25
23 (8.5)
4 (3.6)
19 (13.9)
< 0.001
25–50
31 (11.4)
4 (3.6)
27 (19.7)
51–100
83 (30.6)
33 (30.0)
50 (36.5)
> 100
110 (40.6)
69 (62.7)
41 (29.9)
Condom use during anal receptive sex n (%)
Consistent use
60 (22.1)
12(10.2)
48 (31.4)
Inconsistent use
163 (60.1)
95 (80.5)
68 (44.4)
< 0.001
Never use
48 (17.7)
11 (9.3)
37 (24.2)
Preferred role at anal sex
Mainly receptive
243 (89.7)
113 (95.8)
130 (85.02)
Mainly insertive
28 (10.3)
5 (4.2)
23 (15.0)
0.004
Presence of other STI
160 (59.0)
88 (74.6)
72 (47.1)
< 0.001
History of anal warts during previous 6 months
Yes
205 (68.8)
104 (79.4)
101 (60.5)
< 0.001
*Almost 80% of the study population was invloved in sex work. These categories of sexual partners in last six months i.e., (< 25), (25–50), (51–100), (> 100). Greater number by and-large reflects their "clients"
HIV status (53.8% vs 38.1%; p = 0.014), age at sex work initiation (15.6 vs 17.0 years p = 0.02), inconsistent condom use (74.7% vs 52.3% p = 0.001) and receptive anal sex (95.8% vs 86.4% p = 0.01) were associated with greater prevalence of ASIL detection (Table 2).
Table 2
Socio-demographic and lifestyle characteristics of MSM and transgender women living with and without HIV in Karachi, Pakistan, by Anal Squamous Intraepithelial Lesions (ASIL) status
Characteristics
ASIL positive
(N = 93)
ASIL negative
(N = 178)
p-value
Age in years mean (± SD)
28.2 (± 7.8)
29.2 (± 7.8)
0.31
Age in categories n (% age)
< 25
37 (39.8)
53 (26.8)
0.24
25–29
28 (30.1)
56 (31.5)
30–34
08 (8.6)
28 (15.7)
≥ 35
20 (21.5)
41 (23.0)
Education n (% age)
None
33 (35.1)
48 (27.0)
0.113
Middle school or less
27 (28.70)
41 (23.0)
High school or less
27 (29.8)
77 (43.2)
Graduate
6 (6.4)
12 (6.8)
Marital status n (% age)
Unmarried
74 (79.5)
137 (77.0)
0.924
Married
17 (18.3)
36 (20.2)
Separated/divorced
02 (2.2)
05 (2.8)
Smoking status n (% age)
0.302
No
18 (18.9)
43 (24.4)
0.07
Yes
77 (81.1)
133 (75.6)
Age at smoking initiation in years; mean (± SD)
15.74 (± 4.2)
16.90 (± 4.2)
Average number of cigarettes/day n (% age)
< 10
10–20
> 20
39 (54.2)
25 (34.7)
08 (11.1)
79 (59.4)
40 (30.1)
14 (10.5)
0.758
Duration of smoking in years mean (± SD)
12.0 (± 8.6)
12.5 (± 8.6)
0.68
Alcohol drinking n (% age)
Yes
No
27 (28.4)
68 (71.6)
34 (19.3)
142 (80.7)
0.087
HIV status: n (% age)
Yes
No
50 (53.8)
43 (46.2)
68 (38.1)
110(61.8)
0.014
Sexual identity: n (% age)
Bisexual
Homosexual
Transgender
17 (18.3)
46 (49.5)
30(32.2)
43 (24.4)
102 (57.3)
33 (18.5)
0.047
Age first had sexual intercourse
In years mean (± SD)
15.6 (± 4.4)
17.05 (± 4.8)
0.02
Duration of sex work in years mean (± SD)
12.5 (± 8.2)
12.15 (± 7.9)
0.70
Anal receptive sexual partners the last 6 months n (% age)
< 25
25–50
51–100
> 100
9 (10.2)
6 (15.7)
26 (35.8)
47 (39.6)
14 (8.8)
25 (15.7)
57 (35.8)
63 (39.6)
0.079
Condom use during anal receptive sex n(% age)
Consistent use
Inconsistent use
Never
8 (8.4)
71 (74.7)
16 (16.8)
52 (29.5)
92 (52.3)
32 (18.2)
< 0.001
Preferred anal sex role n (% age)
Mainly receptive
Mainly insertive
91 (95.8)
4 (4.2)
152 (86.4)
24 (13.6)
0.01*
History of anal warts in the previous 6 months n (% age)
Yes
No
71 (74.7)
24 (25.3)
118 (67.0)
66 (33.0)
0.188
*Fisher Exact test p-value
Cytologic assessment
Twenty-seven participants (9%) were excluded due to inadequate sample cellularity making them insufficient for cytologic assessment, leaving 271 participants (HIV positive n = 118; HIV negative n = 153) for the cytological and statistical analyses. Out of 271, a total of 93 (35.0%) MSM and transgender women had any ASIL (ASCUS, LSIL, ASC-H or HSIL) (Fig. 1). Participants living with HIV were significantly more likely to have such an abnormality as compared to those who were HIV negative ((50/118) 42.4%; vs. (43/153) 28.1%) (p ≤ 0.001); (Fig. 2). Age was not associated with the detection of cytological abnormalities (p = 0.31). Just one HIV-negative participant had ASC-H (who had multiple HPV types: LR-HPV 6 & 11 and HR-HPV 35) while three (2.5%; 3/118) participants living with HIV had developed HSIL and all three samples of HSIL were positive for HPV16. HIV infected participants were infected with multiple HPV types than HIV uninfected participants (p < 0.001) (Table 3).
Table 3
Multiplicity of HPV types among any anal squamous intraepithelial lesions (ASIL) and HIV status among MSM and transgender women in Karachi Pakistan
# of types
n (%)
All
N = 271
ASIL positive
n = 93
ASIL negative
n = 178
p-value
HIV positive
n = 118
HIV negative
n = 153
p-value
None
92 (33.9)
0 (13.0)
92 (52.3)
< 0.001*
15 (12.7)
77 (50.3)
< 0.001
One Type
64 (25.1)
32 (40.0)
32 (17.0)
27 (22.9)
23 (15.1)
Two types
84 (29.5)
40 (37.9)
44 (25.0)
47 (39.8)
35 (22.9)
Three types
27 (10.0)
20(21.1)
07 (4.0)
24 (20.3)
12 (7.8)
Four types
4 (1.5)
1 (1.1)
3 (1.7)
5 (4.3)
6 (3.9)
p-value < 0.001 *Fisher exact test p value
×
×
The overall and type specific HPV infection
Overall HPV infection prevalence among study population was 66.4% (180/271). Study participants living with HIV were significantly more infected with HPV (60%; 108/180) than participants living without HIV (40%; 72/180) (p value ≤ 0.001). Among 180 HPV positive participants, 83% (n = 149/180) had at least one HR-HPV type among them. Overall HPV16-positivity among all HPV positive was 35% (n = 63/180).
Anzeige
All participants with ASIL (n = 93) were HPV positive. Within ASIL, the most prevalent HPV types were HPV6/11 (39.8% (n = 37)) followed by HPV16 (35.5% (n = 33), HPV35 (16.1%; n = 15) and HPV18 (15%; n = 14) (Fig. 3) (Additional file 1: Table S1).
×
Abnormal anal cytology associated risk factors
The detection of ASIL was associated with type of HPV infection, in particular HPV16 (PRcrude = 2.11, 95% CI 1.39–3.18), known as one of the high-risk types for cancer development, while HPV type 35 was the second most common oncogenic type among study participants and was associated with 59% increased prevalence of ASIL detection (PRcrude = 1.59, 95% CI 0.99–2.58). Participants living with HIV were more likely to have such an abnormality as compared to those who were HIV negative (PRcrude = 2.33, 95% CI 1.36–2.41). However, all these factors could not appear as an independent risk factor for the greater prevalence of ASIL detection in the multivariate model.
Nevertheless, having any HR-HPV type (16/18/31/33/35/45/52/58) (PR 3.04; 95% CI 1.75–5.26), having another concurrent STI (PR; 2.13, 95% CI 1.28–3.55) and being co-infected with both HPV and HIV (PR 1.75; 95% CI 1.07–2.88) were independently associated with greater prevalence of ASIL detection while adjusting for all other behavioral and sexual variables in the multivariate model (Table 4).
Table 4
Factors associated with any abnormal anal cytology (n = 93) among MSM and transgender women living with (n = 118) and without HIV 9n = 153) in Karachi Pakistan
Determinants
Any abnormal anal cytology
Crude PR (95% CI)
p values
Any abnormal anal cytology
Adjusted PR (95% CI)
HIV status
Negative (ref.)
1.0
positive
2.33 (1.36–2.41)
< 0.001
Any HR-HPV types
No (ref.)
1.0
1.0
Yes
3.8 (2.25–6.51)
< 0.001
3.04 (1.75–5.26)
HPV type 16
No (ref.)
1.0
Yes
2.11 (1.39–3.18)
< 0.001
HPV type 35
No (ref.)
1.0
Ye
1.59 (0.99–2.58)
0.060
Other STIa
No (ref.)
1.0
1.0
Yes
2.77 (1.68–4.59)
< 0.001
2.13 (1.28–3.55)
HIV/HPV co-infection
No (ref.)
1.0
1.0
Yes
2.93 (1.92–4.45)
< 0.001
1.75 (1.07–2.88)
HIV/STIa co-infection
No (ref.)
1.0
Yes
2.04 (1.36–3.04)
0.001
Preferred anal sex role
Insertive (ref.)
1.0
Receptive anal sex
2.62 (0.96–7.13)
0.059
Condom use
Always (ref.)
1.0
Inconsistent use
3.27 (1.57–6.78)
0.002
Never use
2.50 (1.07–5.84)
0.034
Number of sex partners in past 6 monthsb
< 100 (ref.)
1.0
≥ 100
1.43 (0.94–2.17)
0.096
PR prevalence ratio
aSTIs included: gonorrhea and trichomonas
b79.3% of our study participants were sex workers (Table 1)
Discussion
This is the first study to report on the prevalence and risk factors of any anal abnormal cytology among MSM and transgender women in Pakistan. Not unexpectedly, we found a strong association between concurrent high-risk HPV, HIV infection and ASIL. The overall proportion of MSM and transgender women with ASIL was 35%, and those living with HIV were almost twice as likely to have an abnormal cytology compared with HIV negative participants (42.4% versus 28.1%). Moreover, and as expected, the prevalence and number of high-risk HPV types was higher among those with an HIV infection, including HPV16—the primary causal agent for anal cancer. The prevalence of estimates for ASIL in Pakistan are consistent with previous studies from the Asian region [40‐42] and elsewhere [27, 34, 43‐46]. However, the ASIL rates that we found among in MSM in Pakistan are slightly higher than what has been reported from India (27.7%) [47], naturally influenced by study population and sampling. To date, no South Asian studies among MSM (including ours) have used high resolution anoscopy for histologic confirmation of the ASIL diagnosis, which is considered to be the gold standard method [34]. Given that previous studies have shown that anal cytology is less sensitive when diagnosing ASIL compared to the gold standard anal biopsy with the histopathological results [34], the true prevalence of ASIL is likely to be higher than found in our study. Furthermore, and as a matter of concern, we found unexpectedly high proportions of anal cancer precursor lesions, i.e., ASC-US + (35.8%) among young HIV negative MSM. This suggests that a high proportion of MSM and transgender women in Pakistan are at substantial risk for developing anal cancer, in particular those with a concurrent HIV infection. Of note, we found no HSIL cases among HIV-negative participants, possibly partly because they were relatively younger than MSM living with HIV among our participants, but similar to previous findings in an older HIV negative cohort with a mean age of 45 [21]. Although only HSIL is considered to be a precursor of anal cancer, previous studies have shown that about 40% of HIV negative homo- or bisexual men with LSIL at baseline progress to HSIL within only 2–4 years [21, 48]. Moreover, lesions diagnosed as ASC-US may also hide squamous intraepithelial lesions [34, 49], and it is recommended that all individuals with ASC-US or worse on cytology undergo an accurate diagnostic evaluation through HRA guided biopsy as it has high predictive value for Anal Intraepithelial Neoplasia (AIN) [34, 48, 50]. Moreover, one third of ASC-US and LSIL reports are associated with biopsy-diagnosed high-grade AIN [50]. Furthermore, it has been reported that AIN 2 and AIN 3 occurs in about 20% of patients with a negative cytology at baseline after an average of 2 years follow-up [34, 51‐53].
Anzeige
Concurrent infection with more than one high-risk HPV type has been associated with the presence of [28, 54, 55] or progression to AIN [24, 56]. The earlier work of Palefsky et al. has linked having more than one HPV type to a higher risk of progression [48] or incidence [57] of anal squamous intraepithelial lesions. Similarly, a previous study on MSM living with HIV reported a double risk of ASIL when three or more HPV types were present compared to infection with only one type of HPV [58].
MSM living with HIV had a significantly higher prevalence of high-risk HPV as well as multiple HPV types, both low-and high-risk, compared to the HIV negative participants. A possible explanation is HIV-induced immunosuppression that results in a loss of HPV specific immunity, and reactivation or upregulation of a preexisting HPV infection [58, 59]. A larger number of HPV high-risk types among men living with HIV may also indicate an inability to clear HPV infection [60]. A higher risk of reinfection may also be a factor [61], as seen in our study where MSM living with HIV reported both more unprotected anal intercourse and receptive anal sex preference compared to their counterparts who were HIV negative.
Since infection with any HR-HPV type was associated with threefold increase in risk of having any abnormal anal cytology, it would be important to prospectively monitor MSM and transgender women with high-risk HPV infections and/or HPV/HIV coinfection to prevent invasive lesions and intervene on time to prevent anal cancer, but also to learn more about the factors that influence disease progression. We do know that infection with HPV16 or HPV18 significantly increases the risk of progression to high-grade lesions [55, 56], and that concurrent STIs such as gonorrhea and trichomonas also significantly increase the risk of ASIL [60, 62, 63].
Other studies have indicated receptive anal intercourse as a risk factor for anal lesions [62, 64, 65], but anal HPV infection is not limited to men who have receptive sex [66‐68]; it can also be acquired during non-receptive sexual activity. In the current study, abnormal anal cytology was equally prevalent among MSM regardless of anal sex practice, receptive or non-receptive.
Anzeige
This study has some limitations. Firstly, due to lack of equipment and clinicians trained in performing HRA in Pakistan, our analysis of ASIL was based on anal cytology and not on high-resolution anoscopy-driven biopsies, the gold standard for determining disease severity. Awaiting the dispersion of affordable advanced technology, liquid-based cytology, though less sensitive, can be used as a screening tool in high-risk populations in resource-constrained settings as it is convenient, less invasive, cheaper, less time-consuming and requires less expertise than HRA [69]. The fact of the matter is that, recent development in the field of anal cancer screening research has highlighted the potential role for anal Pap testing in providing long-term risk stratification for anal precursors in HIV positive MSM [70]. The sensitivity of anal cytology may also be improved by targeted repeated testing every 12 months among MSM who are HIV-positive but do not yet have signs of anal squamous intraepithelial lesions, or every 2–3 years for HIV-negative MSM [34, 71‐73].
A second study limitation is the cross-sectional design, undermining the evaluation of a causal relationship between HPV and abnormal anal cytology, as well as the impact of, i.e., concurrent STI. Thirdly, selection bias may have been introduced by the recruitment of people living with HIV from an ART center while the others came from a community-based organization working for MSM. However, the ART center is the only large center located in Karachi and it represents all ethnic groups in Pakistan. Moreover, given the cultural and religious barriers related to homosexuality and transgender in Pakistan, recruiting our study subjects from an CBO was the only feasible option.
Conclusion
To the best of our knowledge this is the first study from Pakistan reporting anal HPV associated anal dysplasia in at-risk MSM and transgender women. One third had abnormal anal cytology, and more than half were infected with high-risk HPV. Our study findings indicate the pressing need for further large-scale studies to document the efficacy of anal screening and to develop national guidelines for management of MSM in general and MSM living with HIV in particular. In the absence of the proper infrastructure required for HRA, regular screening with anal cytology of MSM and transgender women may be considered as an initial step in national HIV care and treatment program. Moreover, the benefit and harm analysis of such an approach can only be explored through further screening trials.
Acknowledgements
We thank our all study participants and the staff at our study sites for their continuous cooperation and collaboration. We thank the Sindh Institute of Urology and Transplantation (SIUT) for their financial support in terms of their lab supplies (reagents and the sample collection kits) and contribution to the lab analyses. We are grateful to the staff at the histopathology and molecular laboratories of SIUT who devoted their time and efforts to this project. We are also grateful for the financial contribution from the Dean’s Fund at The Aga Khan Hospital and Medical University, which covered the cost of samples transportation to the SIUT labs from the two study sites. Special thanks to Dr. Asli Kulane for her constant encouragement and guidance to conduct this study. Special thanks to Ms. Parveen Akhter, Dr. Shaheera Shakeel, Dr. Rahema Rashid for their assistance in the conduct of the lab work.
Presentation of this work
This work has been presented in 32nd International Papillomavirus Conference in conjunction with AOGIN 2018, being held in Sydney Australia from October 2–6, 2018. This conference attendance was part of my Doctoral Program and financially being supported by Faculty Development Award by The Aga Khan Hospital and Medical University Pakistan.
Acceptance of the work
This work has been accepted in STI and HIV 2019 World Congress (13th to 17th July 2019 at Vancouver Canada).
Declarations
Ethics approval and consent to participate
The Human Research Ethics Committee of The Aga Khan University (3612-CHS-ERC-15) and Dow University of Health Sciences Karachi Pakistan (IRB-557/DUHS/APPROVAL/2015/84) approved this study. The purpose and the procedure of the study were explained to the participants before written informed consent was obtained. Then written informed consent was obtained from study participants who can read and write. However, those participants who were not able to write, a thumb impression was taken. Moreover, the written informed consent was also obtained from the CBO administration person from where the participants were recruited. The study participants were made assured that their provided information would remained be confidential. Moreover, all the methods were performed in accordance with the relevant guidelines.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Human papillomavirus-associated anal squamous intraepithelial lesions in men who have sex with men and transgender women living with and without HIV in Karachi Pakistan: implications for screening and prevention
verfasst von
Muslima Ejaz Muhammad Mubarak Tazeen Saeed Ali Sören Andersson Anna Mia Ekström
Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.
Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.
Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.
Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.
Update Innere Medizin
Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.